Insulin Resistance, Hyperlipidemia, and Hypertension in Mice Lacking Endothelial Nitric Oxide Synthase
Hervé Duplain(University Hospital of Lausanne), Urs Scherrer(University of Tarapacá), Stéphane Cook(University Hospital of Lausanne), Thierry Pedrazzini(University of Lausanne), Pascal Nicod(University Hospital of Lausanne), Bernard Thorens(University of Lausanne), Péter Vollenweider(University of Lausanne), Mattia Lepori(University Hospital of Lausanne), Cláudio Sartori(University Hospital of Lausanne), Marc Egli(University Hospital of Lausanne), Rémy Burcelin(Institut des Maladies Métaboliques et Cardiovasculaires)
Cited by 535
Related Papers
Metformin alters the gut microbiome of individuals with treatment-naive type 2 diabetes, contributing to the therapeutic effects of the drug
|Nature Medicine|2017|1.6k
The SLC2 (GLUT) family of membrane transporters
|Molecular Aspects of Medicine|2013|1.3k
Uric acid transport and disease
|Journal of Clinical Investigation|2010|848
Nitric oxide release accounts for insulin's vascular effects in humans.
|Journal of Clinical Investigation|1994|759